Details of the Drug

General Information of Drug (ID: DMULLFS)

Drug Name

ND0612

Synonyms

Carbidopa and levodopa; Duodopa; Nakom; Nacom; Sinemet CR; Dopabain; Isicom; Co-careldopa; Levodopa-carbidopa (10:1); Carbidopa-levodopa (1:10); CARBIDOPA AND LEVODOPA; CHF 1512; Rytary; Duopa; Sinemet CR4; L-Tyrosine, 3-hydroxy-, mixt. with (S)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid (10:1); L-Tyrosine, 3-hydroxy-, mixt. with (S)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid; Levodopa / carbidopa; Carbidopa / Levodopa; Carbidopa-levodopa ER; Carbidopa-L-dopa mixt.; Carbidopa-levodopa mixt.; Levodopa/Ca

Indication

Disease Entry	ICD 11	Status	REF
Parkinson disease	8A00.0	Phase 2	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C19H25N3O8
Canonical SMILES: CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN.C1=CC(=C(C=C1CC(C(=O)O)N)O)O
InChI: 1S/C10H14N2O4.C9H11NO4/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6;10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h2-4,12-14H,5,11H2,1H3,(H,15,16);1-2,4,6,11-12H,3,10H2,(H,13,14)/t10-;6-/m00/s1
InChIKey: IVTMXOXVAHXCHI-YXLMWLKOSA-N

Cross-matching ID

PubChem CID: 104778
CAS Number: 57308-51-7
TTD ID: D0VA9Z

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)